You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
26 May 2026 - Neurology specialist Merz Therapeutics GmbH and its Chinese partner Jiangxi Kvvit Pharmaceutical Co Ltd on Tuesday announced an exclusive licence and collaboration agreement for INBRIJA (levodopa inhalation powder) and its proprietary i...
26 May 2026 - Swedish pharmaceutical company OncoZenge AB (Nasdaq First North Growth Market:ONCOZ) announced on Tuesday that it has received European regulatory approval to initiate its pivotal Phase III BEAM-Pain trial of BupiZenge (BZ003) for oral ...
26 May 2026 - French biotech company Transgene (Euronext Paris:TNG) announced on Tuesday that it will present new preclinical data on its TG-MVA prophylactic vaccine candidates against mpox at the World Congress on Infectious Diseases in Barcelona.Th...
26 May 2026 - US pharmaceutical company Eli Lilly and Company (NYSE:LLY) on Monday reported positive Phase 1b Heart-2 study results for VERVE-102, an investigational in vivo base editing medicine designed to durably turn off the PCSK9 gene in the liv...
26 May 2026 - French pharmaceutical company Pierre Fabre Laboratories announced on Monday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of...
26 May 2026 - Italian pharmaceutical and diagnostics company the Menarini Group and its subsidiary Stemline Therapeutics Inc announced on Monday that new data related to elacestrant and tagraxofusp will be presented at the 2026 American Society of Cl...
22 May 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Friday that Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union as a monotherapy for the treatment of adult patients with unr...